-
公开(公告)号:US20220220478A1
公开(公告)日:2022-07-14
申请号:US17618177
申请日:2020-06-18
Inventor: Masafumi MATSUO , Kazuhiro MAETA
IPC: C12N15/113 , A23K20/153 , A23L33/13 , A61K31/712 , A61K31/7125 , A61P19/02 , A61P19/08 , A61P21/02
Abstract: A novel method of myostatin inhibition is provided.
An antisense oligonucleotide of 15-30 bases or a salt or a solvate thereof, wherein the antisense oligonucleotide has a nucleotide sequence complementary to a target site in exon 1 of the myostatin gene and is capable of inhibiting the production of the mRNA of the myostatin gene. A pharmaceutical drug, a food, a feed, an agent for promoting myocyte proliferation and/or hypertrophy, an agent for increasing muscle mass and/or inhibiting muscle weakness, an agent for inhibiting production of the mRNA of the myostatin gene, and an inhibitor of the function of myostatin, each of which comprises the above antisense oligonucleotide or a salt or a solvate thereof.-
公开(公告)号:US20240229036A9
公开(公告)日:2024-07-11
申请号:US18278498
申请日:2022-02-21
Applicant: KNC LABORATORIES CO., LTD.
Inventor: Masafumi MATSUO , Kazuhiro MAETA
IPC: C12N15/113 , A23K20/153 , A23L33/13 , A61P21/00
CPC classification number: C12N15/1136 , A23K20/153 , A23L33/13 , A61P21/00 , C12N2310/11 , C12N2310/321
Abstract: A method of inhibiting the function of myostatin is provided.
An antisense oligonucleotide of 15-30 bases or a salt or a solvate thereof, wherein the antisense oligonucleotide has a nucleotide sequence complementary to a target sequence in exon 3 of the myostatin gene and is capable of allowing the expression of a splicing variant of myostatin. A pharmaceutical drug, a food, a feed, an agent for promoting myocyte proliferation and/or hypertrophy, an agent for increasing muscle mass and/or suppressing muscle weakness, an agent for switching the splicing of the myostatin gene from production of myostatin to production of a splicing variant thereof, an agent for decreasing myostatin signaling, and an anticancer agent, each of which comprises the above antisense oligonucleotide or a salt or a solvate thereof.-
公开(公告)号:US20130096042A1
公开(公告)日:2013-04-18
申请号:US13631096
申请日:2012-09-28
Applicant: BALBIS CO., LTD , Sato Special Oil Co., Ltd. , KNC LABORATORIES CO., LTD.
Inventor: Akihiro ODA
IPC: C10M105/36
CPC classification number: C10M105/36 , C10M105/38 , C10M2207/2835 , C10N2230/02 , C10N2230/06 , C10N2230/74 , C10N2240/02
Abstract: A bearing lubricant composition includes a base oil containing an ester compound (α) represent by the general formula (1), and has a pour point of −30° C. or lower and a viscosity index of 150 or more. [wherein, A1 is a C3-8 linear or branched alkylene group; and at least one of Xa and Xb is a C2-20 linear or branched alkyl ether group, or when it is not an alkyl ether group, it is a C5-13 linear or branched alkyl group.]
Abstract translation: 轴承润滑剂组合物包含含有由通式(1)表示的酯化合物(α)的基油,其倾点为-30℃以下,粘度指数为150以上。 [其中,A1为C3-8直链或支链亚烷基; 并且Xa和Xb中的至少一个是C2-20直链或支链烷基醚基团,或者当其不是烷基醚基团时,它是C5-13直链或支链烷基。
-
4.
公开(公告)号:US12202869B2
公开(公告)日:2025-01-21
申请号:US17435215
申请日:2020-02-26
Inventor: Masafumi Matsuo , Kosuke Okazaki , Kazuhiro Maeta
IPC: C07K14/495 , A23K20/147 , A23L33/18 , A61K38/00
Abstract: A method of inhibiting myostatin signaling via a myostatin splice variant-derived protein is provided. The protein and an expression system thereof are applicable to therapy for diseases in which myostatin is involved.
-
5.
公开(公告)号:US20220135637A1
公开(公告)日:2022-05-05
申请号:US17435215
申请日:2020-02-26
Inventor: Masafumi MATSUO , Kosuke OKAZAKI , Kazuhiro MAETA
IPC: C07K14/495 , A23L33/18 , A23K20/147
Abstract: A method of inhibiting myostatin signaling via a myostatin splice variant-derived protein is provided. The protein and an expression system thereof are applicable to therapy for diseases in which myostatin is involved.
-
公开(公告)号:US20150336876A1
公开(公告)日:2015-11-26
申请号:US14761897
申请日:2014-01-21
Applicant: OSAKA UNIVERSITY , KNC LABORATORIES CO., LTD.
Inventor: Yoshikatsu KANAI , Shushi NAGAMORI , Yoshihiko KITAURA , Masahiro NEYA , Naohiro MATSUSHITA
IPC: C07C217/48 , C07D333/20 , C07D277/28 , C07C217/72 , C07D215/233 , C07D213/68 , C07C255/54 , C07C255/37 , C07D215/26 , C07D209/48 , C07D401/12 , C07D409/06 , C07D405/06 , C07D417/06 , C07D413/06 , C07C271/16
CPC classification number: C07C217/48 , C07C211/09 , C07C217/04 , C07C217/72 , C07C255/37 , C07C255/54 , C07C271/16 , C07C271/20 , C07C317/22 , C07C317/28 , C07C323/20 , C07C323/25 , C07D209/48 , C07D213/68 , C07D215/22 , C07D215/233 , C07D215/26 , C07D263/32 , C07D277/28 , C07D295/08 , C07D307/52 , C07D333/20 , C07D401/12 , C07D403/12 , C07D405/04 , C07D405/06 , C07D409/04 , C07D409/06 , C07D413/04 , C07D413/06 , C07D417/04 , C07D417/06
Abstract: The invention provides a compound having a selective inhibitory activity against highly-expressed LAT-1 in tumor cell. The compound is represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof, and a LAT-1 inhibitor comprising the same.
Abstract translation: 本发明提供对肿瘤细胞中高表达LAT-1具有选择性抑制活性的化合物。 化合物由式(I)表示:其中每个符号如说明书中所定义,或其盐,和含有该化合物的LAT-1抑制剂。
-
公开(公告)号:US09157044B2
公开(公告)日:2015-10-13
申请号:US13631096
申请日:2012-09-28
Applicant: BALBIS CO.,LTD. , Sato Special Oil Co., Ltd. , KNC LABORATORIES CO., LTD.
Inventor: Akihiro Oda
IPC: C10M105/34 , C10M105/38 , C10M129/70 , C10M129/74 , C10M105/36
CPC classification number: C10M105/36 , C10M105/38 , C10M2207/2835 , C10N2230/02 , C10N2230/06 , C10N2230/74 , C10N2240/02
Abstract: A bearing lubricant composition includes a base oil containing an ester compound (α) represent by the general formula (1), and has a pour point of −30° C. or lower and a viscosity index of 150 or more. [wherein, A1 is a C3-8 linear or branched alkylene group; and at least one of Xa and Xb is a C2-20 linear or branched alkyl ether group, or when it is not an alkyl ether group, it is a C5-13 linear or branched alkyl group.]
Abstract translation: 轴承润滑剂组合物包含含有由通式(1)表示的酯化合物(α)的基础油,其倾点为-30℃以下,粘度指数为150以上。 [其中,A1为C3-8直链或支链亚烷基; 并且Xa和Xb中的至少一个是C2-20直链或支链烷基醚基团,或者当其不是烷基醚基团时,它是C5-13直链或支链烷基。
-
公开(公告)号:US11891412B2
公开(公告)日:2024-02-06
申请号:US16958100
申请日:2018-12-26
Applicant: KNC LABORATORIES CO., LTD.
Inventor: Tsuyoshi Fujihara , Kenichi Nakamura , Toru Kurome , Daisuke Sasahara , Akiko Shimahara , Masahiro Neya
IPC: C07H21/04
CPC classification number: C07H21/04
Abstract: The purpose of the present invention is to provide a method for purifying and preparing a highly liposoluble phosphoramidite, as well as a capping reaction using the highly liposoluble phosphoramidite compound, and as well as a method for preparing oligonucleotide by a liquid phase process using a pseudo solid phase protecting group said method comprising the capping reaction step. The present invention also provides a method for preparing a compound represented by formula (I) [wherein, R1, R2 and R3 are defined as described in the Detailed Description], which comprises the following steps: (1) reacting an aliphatic alcohol and a trivalent phosphorus compound in organic solvent in the presence of an activator or an organic base; (2) washing the resulting reaction mixture with water in a reparatory funnel; (3) recovering the organic layer after the step (2) and concentrating it (with the proviso that the organic solvent used in the step (1) is a nitrile solvent, the steps (2) to (3) may be omitted); (4) solubilizing the resulting residue obtained in the step (3) in an aliphatic hydrocarbon solvent (with the proviso that the organic solvent used in the step (1) is an aliphatic hydrocarbon solvent, the steps (2) to (3) may be omitted); (5) washing the aliphatic hydrocarbon solution prepared in the step (4) with a nitrile solvent in a separatory funnel; (6) recovering the aliphatic hydrocarbon solution after the step (5) to obtain a solution of a phosphoramidite compound. Also the present invention provides also a solution containing highly liposoluble phosphoramidite compound obtained by the preparation method, a capping reagent comprising the same solution and optionally an additive, a capping reaction using the same capping reagent, as well as a method for preparing (oligo)nucleotide by using the pseudo solid phase protecting group, said method comprising the capping reaction step.
-
公开(公告)号:US10899790B2
公开(公告)日:2021-01-26
申请号:US16347337
申请日:2017-11-08
Applicant: OSAKA UNIVERSITY , KNC LABORATORIES CO., LTD.
Inventor: Haruo Sugiyama , Fumihiro Fujiki , Masahiro Neya , Shinya Kohno
IPC: C07J63/00 , A61P35/00 , A61K31/16 , A61K31/166 , A61K31/196 , A61K31/215 , A61K31/216 , A61K31/265 , A61K31/27 , A61K31/40 , A61K31/445 , A61K31/5375 , C12N5/0783 , A61K31/19 , A61P37/04 , A61P31/00 , A61K31/44
Abstract: Provided are: a compound represented by formula (I); a retinoid metabolic pathway inhibitor comprising the same; an agent for increasing the ratio of memory T cells; a prophylactic and/or therapeutic agent for cancer or an infectious disease; a cancer immunotherapeutic adjuvant; an immunopotentiator; and a method for preparing a T cell population wherein the ratio of memory T cells is increased, said method comprising using the compound of formula (I).
-
公开(公告)号:US20190284228A1
公开(公告)日:2019-09-19
申请号:US16347337
申请日:2017-11-08
Applicant: OSAKA UNIVERSITY , KNC LABORATORIES CO., LTD.
Inventor: Haruo SUGIYAMA , Fumihiro FUJIKI , Masahiro NEYA , Shinya KOHNO
IPC: C07J63/00 , C12N5/0783 , A61P35/00 , A61K31/215 , A61K31/216 , A61K31/40 , A61K31/445 , A61K31/27 , A61K31/265 , A61K31/16 , A61K31/166 , A61K31/196 , A61K31/5375
Abstract: Provided are: a compound represented by formula (I); a retinoid metabolic pathway inhibitor comprising the same; an agent for increasing the ratio of memory T cells; a prophylactic and/or therapeutic agent for cancer or an infectious disease; a cancer immunotherapeutic adjuvant; an immunopotentiator; and a method for preparing a T cell population wherein the ratio of memory T cells is increased, said method comprising using the compound of formula (I).
-
-
-
-
-
-
-
-
-